Response assessment of anti-angiogenetic therapy by peptide imaging agents
| Project/Area Number |
24591783
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Yokohama City University |
|---|
Principal Investigator |
TATEISHI Ukihide 横浜市立大学, 医学(系)研究科(研究院), 客員教授 (20415524)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | 血管新生 / 薬効判定 |
|---|
| Outline of Final Research Achievements |
Integrin specific peptide-type RGD (Arg-Gly-Asp) ligands were synthesized in order to visualize therapeutic effect of antiangiogenic agents in rat model. Integrin specific peptide-type RGD ligands was considered to be promising tool for monitering therapeutic effect of antiangiogenic agents.
|
Report
(4 results)
Research Products
(13 results)
